Pfiz­er signs up for match-mak­ing ser­vice; In­vestors tell Sanofi: Make a deal, now

• Pfiz­er has signed on with a “match-mak­er” group in Cam­bridge UK that spe­cial­izes in bring­ing bio­phar­ma com­pa­nies and aca­d­e­m­ic in­ves­ti­ga­tors to­geth­er. The Mil­ner Ther­a­peu­tics Con­sor­tium was set up in 2015, at­tract­ing GSK and As­traZeneca, among oth­ers, to the fold.

• Sanofi promised new M&A deals, but just can’t seem to pull a big one off. Two deals have slipped away now. And some of its big in­vestors are get­ting worked up about the lack of progress un­der CEO Olivi­er Brandi­court.  “The com­pa­ny needs a growth dri­ver and must make an ac­qui­si­tion. Time is run­ning out,” Olivi­er David of Ve­ga In­vest­ment Man­agers tells Reuters.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER